Preliminary radiochemical and biological studies on the liposome encapsulated platinum-[125I]iohistamine complex

Nuclear Medicine Review

Volumn 5, Issue 2, 2002, Pages 145-149

  Garnuszek, Piotr ^a   Licińska, Iwona ^a  

^a NATIONAL MEDICINES INSTITUTE   (Poland)

Author keywords

Cationic liposomes; Platinum 125 iodohistamine complex; Spontaneous mammary adenocarcinoma in C3H mice; Tumour bearing C3H 16C mice

Indexed keywords

CISPLATIN; HISTAMINE DERIVATIVE; IODINE 125; LIPOSOME; PLATINUM COMPLEX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG UPTAKE; ENCAPSULATION; FEMALE; IN VIVO STUDY; LIPID MEMBRANE; LIVER; LUNG; MACROPHAGE; MOUSE; NONHUMAN; RADIOACTIVITY; SPLEEN;

EID: 0036927083     PISSN: 15069680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Chenoufi N, Raoul JL, Lescoat G, Brissot P, Bourguet P. In vitro demonstration of synergy between radionuclide and chemotherapy. J Nucl Med 1998; 39 (5): 900-903.
2. Sauer R, Birkenhake S, Kuhn R, Wittekind C, Schrott KM, Martus P. Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer. Int J Radiat Oncol Biol Phys 1998; 40 (1): 121-127.
3. Mastrangelo R, Tornesello A, Riccardi R, Lasorella A, Mastrangelo S, Mancini A et al. A new approach in the treatment of stage IV neuroblastoma using a combination of [131I]meta-iodobenzylguanidine (MIBG) and cisplatin. Eur J Cancer 1995; 31A (4): 606-611.
4. Bachaud JM, Chatelut E, Canal P, Albin N, Yardeni E, David JM, et al. Radiotherapy with concomitant continuous cisplatin infusion for unresectable tumors of the upper aerodigestive tract: results of a phase I study. Am J Clin Oncol 1997; 20 (1): 1-5.
5. Dolling JA, Boreham DR, Brown DL, Raaphorst GP, Mitchel RE. Cisplatin-modification of DNA repair and ionizing radiation lethality in yeast, Saccharomyces cerevisiae. Mutat Res 1999; 433 (2): 127-136.
6. Garnuszek P, Maurin JK, Witowska-Jarosz J, Ptasiewicz-Bak B. Synthesis and characterisation of platinum(II) complexes with histamine and iodohistamine. Inorg Chim Acta 2002; 338 C: 119-126.
7. Garnuszek P, Licińska I, Skierski JS. Koronkiewicz M, Mirowski M, Wiercioch R, Mazurek AP. Biological investigation of the platinum(II)-[*I]iodohistamine complexes of potential synergistic anti-cancer activity. Nucl Med Biol 2002; 29 (2): 169-175.
8. Uchegbu IF. Science in pharmacy. Parenteral drug delivery: 1. Pharm J 1999; 263 (7060): 309-318.
9. Frézard F. Liposomes: from biophysics to the design of peptide vaccines. Braz J Med Biol Res 1999; 32 (2): 181-189.
10. Martin FJ. Future Prospects for Stealth Liposomes in Cancer Therapy. Oncology 1997; 11 (10): 63-68.
11. Farhood H, Gao X, Son K, Yang YY, Lazo JS, Huang L. et al. Cationic liposomes for direct gene transfer in therapy of cancer and other diseases. Gynecol Oncol 2000; 78 (2): 143-147.
12. Iinuma H, Maruyama K, Okinaga K, Sasaki K, Sekine T, Ishida O et al. Intracellular targeting therapy of cisplatin-encapsulated transferrin-polyethylene glycol liposome on peritoneal dissemination of gastric cancer. Int J Cancer 2002; 99 (1): 130-137.
13. Burger KN, Staffhorst RW, de Vijlder HC, Velinova MJ, Bomans PH, Frederik PM, de Kruijff B. Nanocapsules: lipid-coated aggregates of cisplatin with high cytotoxicity. Nat Med 2002; 8 (1): 81-84.
14. Ewen C, Perera A, Hendry JH, McAuliffe CA, Sharma H, Fox BW. An autoradiographic study of the internal localisation and retention of cisplatin, iproplatin and paraplatin. Cancer Chemother. Pharmacol 1988; 22 (3): 241-245.
15. Areberg J, Bjorkman S, Einarsson L, Frankenberg B, Lundqvist H, Mattsson S, et al. Gamma camera imaging of platinum in tumours and tissues of patients after administration of 191Pt-cisplatin. Acta Oncol 1999; 38 (2): 221-228.
16. Corbett TH. Griswold DP Jr, Roberts BJ, Peckham JC, Schabel FM Jr. Biology and therapeutic response of a mouse mammary adenocarcinoma (16/C) and its potential as a model for surgical adjuvant chemotherapy. Cancer Treat Rep 1978; 62 (10): 1471-1488.
17. Wood PJ, Stratford IJ, Sansom JM, Cattanach BM, Quinney RM, Adams GE. The response of spontaneous and transplantable murine tumors to vasoactive agents measured by 31P magnetic resonance spectroscopy. Int J Radiat Oncol Biol Phys 1992; 22 (3): 473-476.
18. Porteous DJ, Dorin JR, McLachlan G, Davidson Smith H, Davidson H, Stevenson BJ et al. Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Therapy 1997; 4: 210-218.